Evaluates short- and long-term impacts of translational science using standardized tools for researchers, indicating broader applications.
Objectives/Goals: Our hub’s annual survey evaluates the impacts of our institute’s support on investigators’ research productivity and real-world impacts. We have piloted new measures to establish valid and reliable approaches to measuring short- and long-term translational science impacts of interest to the CTSAs. Methods/Study Population: SC CTSI developed an annual survey to assess our institute’s impact on investigators’ research productivity, sustained engagement in behaviors of translational scientists, and real-world impacts. In 2023, we piloted two versions of the TSBM 30-elements across four domains. In 2025, we piloted a 20-item hallmarks of a Translational Scientist scale covering collaboration, mindset, capacity building, and planning for D&I and real-world impact. After online administration to over 700 CTSI-supported USC and CHLA-affiliated researchers, data are analyzed using descriptive statistics and exploratory factor analysis, to assess factor structure, item loadings, validity, and reliability. Results/Anticipated Results: Prior analyses showed that 27/30 TSBM items aligned well with intended domains, with clinical/medical and policy benefits demonstrating strong internal consistency. Current analyses will establish the psychometric properties of the new Hallmarks of a Translational Scientist scale and sub-domains. Refinement of items and best practices will be shared. Anticipated outcomes include standardized tools for CTSA evaluators to assess short- and long-term translational science impacts. The survey aims to enable consistent measurement of translational science benefits, support longitudinal tracking, and strengthen cross-hub comparisons of real-world impact beyond research productivity. Discussion/Significance of Impact: The validated impact measures shared in this session advance translational science evaluation. Standardized items assessing translational science short- and long-term impacts are of interest to the CTSA community and any organization engaged in translational science capacity building.
No takes yet. Share an insight, caveat, or question.
Maccalla et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: